Outcome of Board Meeting-Announcement U/Reg_30
BEEKAY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board approved unaudited financial results for Q3 and nine months ended 31 Dec 2025. Standalone revenue rose ~6.2% YoY to Rs 28,792 lakhs in Q3, with 9M revenue up ~12.1% to Rs 83,642 lakhs. However, profitability weakened sharply: Q3 standalone PAT fell to Rs 1,325 lakhs (vs Rs 2,249 lakhs a year ago) and 9M PAT dropped ~35% to Rs 5,553 lakhs (vs Rs 8,491 lakhs), pulling 9M EPS down to Rs 29.11 from Rs 44.52. Standalone EBITDA margin compressed noticeably in 9M FY26 versus 9M FY25, with other expenses and depreciation rising faster than revenue. Consolidated results were broadly in line with standalone. The auditor (Rustagi & Associates) issued an unmodified limited review report. Separately, Mr. Manav Bansal stepped down as CFO (continuing as Whole-time Director) and Mr. Ashok Agarwal was appointed as the new CFO with effect from 14 Feb 2026.
Mixed picture for shareholders: top-line growth is healthy but the steep drop in profit and margin compression signal cost-side pressures (other expenses, depreciation, finance costs) that investors may view negatively in the near term. The CFO transition is a governance change to monitor but Mr. Bansal stays on as WTD, providing continuity.